상처 봉합 시장 : 시장 규모, 점유율, 성장 및 업계 분석, 지역별 동향, 예측(2026-2034년)

Growth Factors of wound closure Market

The global wound closure market was valued at USD 15.10 billion in 2025 and is projected to grow from USD 16.09 billion in 2026 to USD 28.34 billion by 2034, registering a CAGR of 7.33% during the forecast period. North America dominated the global wound closure market with a 37.80% market share in 2025, supported by advanced healthcare infrastructure, increasing surgical procedures, and rapid adoption of technologically advanced wound closure products.

Wound closure plays a critical role in surgical and emergency care by promoting faster healing, minimizing infection risks, and improving patient outcomes. Products such as sutures, staplers, hemostatic agents, and surgical adhesives are increasingly being used across general surgery, orthopedic, cardiovascular, gynecological, and ophthalmic procedures. The growing prevalence of chronic diseases, rising aging population, increasing trauma cases, and the shift toward minimally invasive surgeries are creating strong demand for innovative wound closure solutions. Additionally, continuous product innovation and favorable regulatory approvals are supporting long-term market expansion.

Market Trends

One of the major trends shaping the wound closure market is the growing preference for advanced wound closure technologies over conventional methods. Healthcare professionals are increasingly adopting absorbable sutures, antibacterial wound sealants, powered staplers, and advanced hemostatic agents due to their superior healing performance, lower infection risk, and improved surgical outcomes.

Another important trend is the rapid adoption of minimally invasive surgical procedures. Since these procedures require smaller incisions and faster recovery, they have significantly increased demand for precision wound closure devices that reduce scarring, minimize bleeding, and shorten hospital stays. Manufacturers are also investing heavily in research and development to introduce next-generation products with enhanced safety and efficiency.

Market Drivers

The increasing prevalence of chronic diseases remains one of the strongest drivers for the wound closure market. Rising cases of cardiovascular disorders, orthopedic diseases, arthritis, diabetes, and obesity have led to a significant increase in surgical procedures worldwide. Growing geriatric populations, who are more susceptible to chronic illnesses, are further expanding the demand for advanced wound closure products.

The rising number of trauma and accident cases also supports market growth by increasing emergency surgical interventions. Furthermore, ongoing technological advancements, growing awareness regarding infection prevention, and continuous product launches by leading manufacturers are accelerating the adoption of advanced wound closure solutions across hospitals and surgical centers.

Market Restraints

Despite strong growth prospects, the high cost of advanced wound closure devices remains a major challenge. Powered staplers, premium sutures, and advanced hemostatic agents are significantly more expensive than conventional alternatives, limiting their adoption in developing and low-income countries.

Additionally, inadequate reimbursement policies in several emerging markets reduce patient access to advanced surgical procedures. Product recalls due to manufacturing defects, contamination, labeling issues, or quality concerns also create challenges for manufacturers by affecting product confidence and market reputation.

Market Segmentation

Based on product type, the sutures segment is expected to dominate the global market with a 39.45% market share in 2026. Increasing surgical procedures worldwide, technological improvements in absorbable sutures, and growing preference for infection-resistant products continue to drive this segment. Hemostatic agents are projected to witness strong growth due to rising product innovations, while staplers continue gaining popularity with the introduction of powered and digitally enabled surgical systems.

By application, the general surgery segment is projected to account for the largest market share of 22.62% in 2026, supported by the growing number of appendectomies, hernia repairs, and laparoscopic procedures. The cardiology segment is expected to register the fastest growth owing to the increasing burden of cardiovascular diseases and rising cardiac surgeries globally.

Based on end user, hospitals and ambulatory surgical centers (ASCs) are expected to dominate the market with a 69.90% share in 2026 due to higher patient admissions, advanced healthcare facilities, and favorable reimbursement systems.

Regional Analysis

North America remained the leading regional market with a value of USD 5.71 billion in 2025 and is expected to reach USD 6.10 billion in 2026. The region benefits from advanced healthcare infrastructure, increasing surgical volumes, strong reimbursement policies, and continuous product innovation. The U.S. continues to dominate regional demand due to the high prevalence of chronic diseases and growing adoption of advanced wound closure technologies.

Europe accounted for USD 3.61 billion in 2025 and is projected to reach USD 3.85 billion in 2026, supported by increasing chronic disease prevalence, rising surgical procedures, and government initiatives promoting infection prevention during surgeries.

Asia Pacific generated USD 3.66 billion in 2025 and is expected to grow to USD 3.90 billion in 2026. Rapid healthcare infrastructure development, rising geriatric population, increasing surgical procedures, and expanding regulatory approvals are driving strong regional growth, particularly in China, Japan, and India.

Latin America reached USD 1.29 billion in 2025 and is projected to grow to USD 1.37 billion in 2026, while the Middle East & Africa market increased from USD 0.83 billion in 2025 to USD 0.87 billion in 2026, supported by improving healthcare facilities and growing surgical volumes.

Competitive Landscape

The global wound closure market remains highly competitive with major companies focusing on product innovation, regulatory approvals, acquisitions, and global expansion. Leading companies include Johnson & Johnson Services, Inc., Baxter, Medtronic, Stryker, Solventum, Smith+Nephew, B. Braun SE, Boston Scientific Corporation, Frankenman International Ltd., CooperSurgical Inc., Intuitive Surgical, MANI, Inc., Artivion, Inc., CP Medical (Riverpoint Medical), CONMED Corporation, and Genesis Medtech. Continuous investments in advanced wound closure technologies, powered staplers, absorbable sutures, and hemostatic products are expected to strengthen market competition over the forecast period.

Key Industry Developments

Recent industry developments continue to enhance innovation in wound closure technologies. In March 2024, Intuitive Surgical received FDA clearance for its next-generation da Vinci 5 robotic surgical system. In February 2024, Boston Scientific reported positive clinical results for its OverStitch endoscopic suturing system. Healthium Medtech introduced its TRUMAS absorbable sutures in August 2023, while Artivion and Baxter secured FDA approvals for the PERCLOT Absorbable Hemostatic System in 2023. Earlier, Johnson & Johnson launched the ECHELON 3000 Stapler, strengthening its advanced surgical device portfolio.

Conclusion

The global wound closure market is expected to witness steady expansion through 2034, driven by the increasing burden of chronic diseases, growing surgical procedures, rapid adoption of minimally invasive techniques, and continuous technological innovation in wound management products. While high product costs and occasional recalls remain challenges, ongoing investments in advanced sutures, staplers, hemostatic agents, and regulatory approvals are expected to create significant growth opportunities. As healthcare systems continue emphasizing safer surgical outcomes and faster patient recovery, the wound closure market is well positioned for sustained long-term growth.

Segmentation By Product Type

• Sutures
  • Absorbable
  • Non-Absorbable
• Hemostatic Agents
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • Others
• Staplers
  • Powered
  • Manual
• Others

By Application

• Orthopedics
• Gynecology and Obstetrics
• General Surgery
• Ophthalmology
• Cardiology
• Others

By End-user

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

• North America (By Product Type, By Application, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Product Type, By Application, By End-user, and By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, By Application, By End-user, and By Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, By Application, By End-user, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Application, By End-user, and By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Key Procedures, by Key Countries/Region, 2025
• 4.2. New Product Launches - by Key Players
• 4.3. Technological Advancements in Wound Closure Market
• 4.4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)

5. Global Wound Closure Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Sutures
    • 5.1.1.1. Absorbable
    • 5.1.1.2. Non-absorbable
  • 5.1.2. Hemostatic Agents
    • 5.1.2.1. Active Hemostats
    • 5.1.2.2. Passive Hemostats
    • 5.1.2.3. Combination Hemostats
    • 5.1.2.4. Others
  • 5.1.3. Staplers
    • 5.1.3.1. Powered
    • 5.1.3.2. Manual
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Orthopedics
  • 5.2.2. Gynecology and Obstetrics
  • 5.2.3. General Surgery
  • 5.2.4. Ophthalmology
  • 5.2.5. Cardiology
  • 5.2.6. Others
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Sutures
    • 6.1.1.1. Absorbable
    • 6.1.1.2. Non-absorbable
  • 6.1.2. Hemostatic Agents
    • 6.1.2.1. Active Hemostats
    • 6.1.2.2. Passive Hemostats
    • 6.1.2.3. Combination Hemostats
    • 6.1.2.4. Others
  • 6.1.3. Staplers
    • 6.1.3.1. Powered
    • 6.1.3.2. Manual
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Orthopedics
  • 6.2.2. Gynecology and Obstetrics
  • 6.2.3. General Surgery
  • 6.2.4. Ophthalmology
  • 6.2.5. Cardiology
  • 6.2.6. Others
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Wound Closure Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Sutures
    • 7.1.1.1. Absorbable
    • 7.1.1.2. Non-absorbable
  • 7.1.2. Hemostatic Agents
    • 7.1.2.1. Active Hemostats
    • 7.1.2.2. Passive Hemostats
    • 7.1.2.3. Combination Hemostats
    • 7.1.2.4. Others
  • 7.1.3. Staplers
    • 7.1.3.1. Powered
    • 7.1.3.2. Manual
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Orthopedics
  • 7.2.2. Gynecology and Obstetrics
  • 7.2.3. General Surgery
  • 7.2.4. Ophthalmology
  • 7.2.5. Cardiology
  • 7.2.6. Others
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Wound Closure Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Sutures
    • 8.1.1.1. Absorbable
    • 8.1.1.2. Non-absorbable
  • 8.1.2. Hemostatic Agents
    • 8.1.2.1. Active Hemostats
    • 8.1.2.2. Passive Hemostats
    • 8.1.2.3. Combination Hemostats
    • 8.1.2.4. Others
  • 8.1.3. Staplers
    • 8.1.3.1. Powered
    • 8.1.3.2. Manual
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Orthopedics
  • 8.2.2. Gynecology and Obstetrics
  • 8.2.3. General Surgery
  • 8.2.4. Ophthalmology
  • 8.2.5. Cardiology
  • 8.2.6. Others
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Sutures
    • 9.1.1.1. Absorbable
    • 9.1.1.2. Non-absorbable
  • 9.1.2. Hemostatic Agents
    • 9.1.2.1. Active Hemostats
    • 9.1.2.2. Passive Hemostats
    • 9.1.2.3. Combination Hemostats
    • 9.1.2.4. Others
  • 9.1.3. Staplers
    • 9.1.3.1. Powered
    • 9.1.3.2. Manual
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Orthopedics
  • 9.2.2. Gynecology and Obstetrics
  • 9.2.3. General Surgery
  • 9.2.4. Ophthalmology
  • 9.2.5. Cardiology
  • 9.2.6. Others
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Wound Closure Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Sutures
    • 10.1.1.1. Absorbable
    • 10.1.1.2. Non-absorbable
  • 10.1.2. Hemostatic Agents
    • 10.1.2.1. Active Hemostats
    • 10.1.2.2. Passive Hemostats
    • 10.1.2.3. Combination Hemostats
    • 10.1.2.4. Others
  • 10.1.3. Staplers
    • 10.1.3.1. Powered
    • 10.1.3.2. Manual
  • 10.1.4. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Orthopedics
  • 10.2.2. Gynecology and Obstetrics
  • 10.2.3. General Surgery
  • 10.2.4. Ophthalmology
  • 10.2.5. Cardiology
  • 10.2.6. Others
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Hospitals & ASCs
  • 10.3.2. Specialty Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Baxter
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Medtronic
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Artivion, Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Stryker
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. 3M
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. CP Medical (Riverpoint Medical)
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Boston Scientific Corporation
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Smith+Nephew
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. B. Braun SE
    • 11.2.10.1. Overview
    • 11.2.10.2. Products
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)
  • 11.2.11. MANI, INC.
    • 11.2.11.1. Overview
    • 11.2.11.2. Products
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. Financials (Based on Availability)
  • 11.2.12. CONMED Corporation
    • 11.2.12.1. Overview
    • 11.2.12.2. Products
    • 11.2.12.3. SWOT Analysis
    • 11.2.12.4. Recent Developments
    • 11.2.12.5. Strategies
    • 11.2.12.6. Financials (Based on Availability)
  • 11.2.13. Genesis Medtech
    • 11.2.13.1. Overview
    • 11.2.13.2. Products
    • 11.2.13.3. SWOT Analysis
    • 11.2.13.4. Recent Developments
    • 11.2.13.5. Strategies
    • 11.2.13.6. Financials (Based on Availability)
  • 11.2.14. CooperSurgical Inc.
    • 11.2.14.1. Overview
    • 11.2.14.2. Products
    • 11.2.14.3. SWOT Analysis
    • 11.2.14.4. Recent Developments
    • 11.2.14.5. Strategies
    • 11.2.14.6. Financials (Based on Availability)
  • 11.2.15. Intuitive Surgical
    • 11.2.15.1. Overview
    • 11.2.15.2. Products
    • 11.2.15.3. SWOT Analysis
    • 11.2.15.4. Recent Developments
    • 11.2.15.5. Strategies
    • 11.2.15.6. Financials (Based on Availability)
  • 11.2.16. Frankenman International Ltd.
    • 11.2.16.1. Overview
    • 11.2.16.2. Products
    • 11.2.16.3. SWOT Analysis
    • 11.2.16.4. Recent Developments
    • 11.2.16.5. Strategies
    • 11.2.16.6. Financials (Based on Availability)